Bayesian Reanalysis of Enzalutamide Plus Androgen Deprivation Therapy in Japanese Patients With Metastatic Hormone‐Sensitive Prostate Cancer: A Methodological Complement to Frequentist Analysis From the <scp>ARCHES</scp> Trial
Yasuhisa Fujii is an Editorial Board member of the International Journal of Urology and a coauthor of this article. To minimize bias, he was excluded from all editorial decision-making related to the acceptance of this article for publication. The other authors declare no conflicts of interest.
Authors
- Hiroshi Fukushima (ORCID: https://orcid.org/0000-0001-7548-1580)
- Akihiro Hirakawa
- Hitoshi Masuda (ORCID: https://orcid.org/0000-0002-9182-8481)
- Soichiro Yoshida (ORCID: https://orcid.org/0000-0003-2757-8083)
- Yasuhisa Fujii (ORCID: https://orcid.org/0000-0002-6761-3229)
- Shugo Yajima
Institutions
- Tokyo Medical and Dental University (JP)
- National Cancer Center Hospital East (JP)
- Institute of Science Tokyo (JP)
Publication Details
- Journal
- International Journal of Urology
- Published
- 2025-10-12
- DOI
- https://doi.org/10.1111/iju.70256
- Citations
- 3
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 2.81